Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy

NCT00469729 is registered in ClinicalTrials.gov with Gamida Cell -Teva Joint Venture Ltd. as lead sponsor.

NCT NCT00469729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy
Lead sponsor
Gamida Cell -Teva Joint Venture Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2007
Completion date
June 30, 2015
Enrollment
101 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, chronic myeloid leukemia, hematologic malignancies, hodgkin's disease, lymphoid leukemia, myelodysplastic syndromes, non-hodgkin's lymphoma